When French Research Sheds Light on the Vital Mechanisms of Coagulation – Cécile Denis Awarded the 2025 Jean-Paul Binet Prize
Stanislas Conseiller, Philanthropy and Fundraising Development Officer at the Paris-Saclay School of Medicine, shared on LinkedIn:
“When French research sheds light on the vital mechanisms of coagulation and paves the way for new therapies!
Congratulations to Cécile Denis on receiving the 2025 Jean-Paul Binet Prize
Awarded by the French Medical Research Foundation, it is a well-deserved distinction for his work at the head of the Haemostasis, Inflammation, Thrombosis Unit.
Understanding coagulation to transform the management of vascular diseases.
His team deciphers the essential mechanisms of the coagulation cascade, in particular the role of von Willebrand factor (VWF). Their work has highlighted still little-known interactions between these blood components and the vascular wall, revealing:
– the central role of the VWF in pathologies such as strokes, where thrombosis and inflammation are intimately linked,
– the unexpected involvement of VWF in the survival of cancer cells.
These fundamental advances pave the way for new diagnostic and therapeutic strategies for complex vascular or hemorrhagic diseases, which have long been difficult to treat.
I had already had the opportunity to mention one of the innovations that came out of this group: the development of a nanobody capable of stabilizing VWF and correcting coagulation in patients with von Willebrand disease, a real glimmer of hope for improving their care.
This Prize illustrates not only the scientific excellence of Cécile Denis and her team, but also the crucial importance of supporting fundamental research in hemostasis, the basis for innovative treatments for tomorrow.
Congratulations to the whole team!”

Find more posts on Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization